To What Extent Can Preventive Treatments Prevent Damage From Systemic Lupus Erythematosus?

[1]  D. Gladman,et al.  Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus , 2011, Arthritis care & research.

[2]  Susana Gordo,et al.  Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage , 2010, Arthritis care & research.

[3]  R. Telles,et al.  Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics , 2010, Lupus.

[4]  M. Petri,et al.  Development and initial validation of a self‐assessed lupus organ damage instrument , 2010, Arthritis care & research.

[5]  J. Reveille,et al.  Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort , 2010, Arthritis care & research.

[6]  C. Pineau,et al.  Cigarette Smoking and Cutaneous Damage in Systemic Lupus Erythematosus , 2009, The Journal of Rheumatology.

[7]  J. Reveille,et al.  Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX) , 2009, Lupus.

[8]  J. Reveille,et al.  Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort , 2009, Lupus.

[9]  D. Isenberg,et al.  Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. , 2009, Rheumatology.

[10]  M. Hernán,et al.  Prednisone, Lupus Activity, and Permanent Organ Damage , 2009, The Journal of Rheumatology.

[11]  M. García-Carrasco,et al.  Risk factors of vertebral fractures in women with systemic lupus erythematosus , 2009, Clinical Rheumatology.

[12]  V. Werth,et al.  The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus. , 2009, Autoimmunity reviews.

[13]  J. Reveille,et al.  Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. , 2008, Rheumatology.

[14]  M. Abrahamowicz,et al.  Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. , 2008, Arthritis and rheumatism.

[15]  J. Reveille,et al.  Systemic Lupus Erythematosus in a Multiethnic US Cohort (LUMINA): LXI. Value of C-Reactive Protein as a Marker of Disease Activity and Damage , 2008, The Journal of Rheumatology.

[16]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[17]  M. Petri,et al.  High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus. , 2008, Seminars in arthritis and rheumatism.

[18]  M. Petri,et al.  Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort , 2008, Lupus.

[19]  J. Reveille,et al.  Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII) , 2008, Annals of the rheumatic diseases.

[20]  J. Reveille,et al.  Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV) , 2007, Annals of the rheumatic diseases.

[21]  M. Petri,et al.  Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. , 2007, Arthritis and rheumatism.

[22]  C. Ohlsson,et al.  Prevalence and risk factors of osteoporosis in female SLE patients-extended report. , 2007, Rheumatology.

[23]  D. Symmons,et al.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.